ABE has also demonstrated promising effectiveness in correcting mutations in CD3D causing severe combined immunodeficiency (SCID), and restoring normal expression of CD3δ, which is necessary for normal thymopoiesis [72]. The gene discussed is CD3D; the disease is severe combined immunodeficiency.